FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367174013> ?p ?o ?g. }

• W4367174013 abstract "As a hallmark of COVID-19 progression, lymphopenia alongside its subtle immune disturbance has been widely reported, but yet to be thoroughly elucidated. Aiming at exploring clinical immune biomarkers with accessibility in the current and acute omicron epidemic abrupted in China post-control era, we design a real-world prospective observation cohort in Peking Union Medical College Hospital to describe immunological, haematological profiles inducing lymphocyte subsets related to SARS-CoV-2 infection. In this COVID-19 cohort, we enrolled 17 mild/moderate (M/M), 24 severe (S) and 25 critical (C) patients. The dynamics of lymphocytes of COVID-19 demonstrated that the sharp decline of NK, CD8+, and CD4+ T cell counts was the main contributor to lymphopenia in the S/C group, compared to the M/M group. Expressions of activation marker CD38 and proliferation marker Ki-67 both in CD8+ T and NK cells were significantly higher in all COVID-19 patients than that in healthy donors, independent of disease severity. The subsequent analysis showed in contrast to the M/M group, NK and CD8+ T cell counts remained low-level after therapy in the S/C group. CD38 and Ki-67 expressions in NK and CD8+ T cells still stay at a high level, despite active treatment. Targeting relatively elderly patients with SARS-CoV-2 infection, severe COVID-19 features the unreversible reduction of NK and CD8+ T cells with persistent activation and proliferation, which assist clinicians in early recognizing and saving severe or critical COVID-19 patients. Given that immunophenotype, the new immunotherapy improving NK and CD8+ T lymphocyte antiviral efficiency should be considered." @default.
• W4367174013 created "2023-04-28" @default.
• W4367174013 creator A5008164224 @default.
• W4367174013 creator A5016140099 @default.
• W4367174013 creator A5021998018 @default.
• W4367174013 creator A5022095533 @default.
• W4367174013 creator A5022510096 @default.
• W4367174013 creator A5028677618 @default.
• W4367174013 creator A5031998757 @default.
• W4367174013 creator A5044459845 @default.
• W4367174013 creator A5052344563 @default.
• W4367174013 creator A5057518610 @default.
• W4367174013 creator A5077251841 @default.
• W4367174013 creator A5085277958 @default.
• W4367174013 date "2023-05-15" @default.
• W4367174013 modified "2023-10-16" @default.
• W4367174013 title "The unreversible reduced but persistent activated NK and CD8⁺ T cells in severe/critical COVID-19 during omicron pandemic in China" @default.
• W4367174013 cites W2085402152 @default.
• W4367174013 cites W2129203060 @default.
• W4367174013 cites W3001118548 @default.
• W4367174013 cites W3009859788 @default.
• W4367174013 cites W3011812996 @default.
• W4367174013 cites W3012345473 @default.
• W4367174013 cites W3023991776 @default.
• W4367174013 cites W3025320502 @default.
• W4367174013 cites W3032985762 @default.
• W4367174013 cites W3137125239 @default.
• W4367174013 cites W3171160125 @default.
• W4367174013 cites W3193480463 @default.
• W4367174013 cites W3198194327 @default.
• W4367174013 cites W3204565143 @default.
• W4367174013 cites W3214371155 @default.
• W4367174013 cites W4207080708 @default.
• W4367174013 cites W4303961646 @default.
• W4367174013 cites W4307371005 @default.
• W4367174013 cites W4307871402 @default.
• W4367174013 cites W4309734394 @default.
• W4367174013 cites W4310643051 @default.
• W4367174013 cites W4316014100 @default.
• W4367174013 doi "https://doi.org/10.1080/22221751.2023.2208679" @default.
• W4367174013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37102227" @default.
• W4367174013 hasPublicationYear "2023" @default.
• W4367174013 type Work @default.
• W4367174013 citedByCount "0" @default.
• W4367174013 crossrefType "journal-article" @default.
• W4367174013 hasAuthorship W4367174013A5008164224 @default.
• W4367174013 hasAuthorship W4367174013A5016140099 @default.
• W4367174013 hasAuthorship W4367174013A5021998018 @default.
• W4367174013 hasAuthorship W4367174013A5022095533 @default.
• W4367174013 hasAuthorship W4367174013A5022510096 @default.
• W4367174013 hasAuthorship W4367174013A5028677618 @default.
• W4367174013 hasAuthorship W4367174013A5031998757 @default.
• W4367174013 hasAuthorship W4367174013A5044459845 @default.
• W4367174013 hasAuthorship W4367174013A5052344563 @default.
• W4367174013 hasAuthorship W4367174013A5057518610 @default.
• W4367174013 hasAuthorship W4367174013A5077251841 @default.
• W4367174013 hasAuthorship W4367174013A5085277958 @default.
• W4367174013 hasBestOaLocation W43671740131 @default.
• W4367174013 hasConcept C10205521 @default.
• W4367174013 hasConcept C126322002 @default.
• W4367174013 hasConcept C154317977 @default.
• W4367174013 hasConcept C159912055 @default.
• W4367174013 hasConcept C167672396 @default.
• W4367174013 hasConcept C196166836 @default.
• W4367174013 hasConcept C202751555 @default.
• W4367174013 hasConcept C203014093 @default.
• W4367174013 hasConcept C2779134260 @default.
• W4367174013 hasConcept C28328180 @default.
• W4367174013 hasConcept C3008058167 @default.
• W4367174013 hasConcept C524204448 @default.
• W4367174013 hasConcept C54355233 @default.
• W4367174013 hasConcept C553184892 @default.
• W4367174013 hasConcept C55493867 @default.
• W4367174013 hasConcept C71924100 @default.
• W4367174013 hasConcept C72563966 @default.
• W4367174013 hasConcept C86803240 @default.
• W4367174013 hasConcept C8891405 @default.
• W4367174013 hasConceptScore W4367174013C10205521 @default.
• W4367174013 hasConceptScore W4367174013C126322002 @default.
• W4367174013 hasConceptScore W4367174013C154317977 @default.
• W4367174013 hasConceptScore W4367174013C159912055 @default.
• W4367174013 hasConceptScore W4367174013C167672396 @default.
• W4367174013 hasConceptScore W4367174013C196166836 @default.
• W4367174013 hasConceptScore W4367174013C202751555 @default.
• W4367174013 hasConceptScore W4367174013C203014093 @default.
• W4367174013 hasConceptScore W4367174013C2779134260 @default.
• W4367174013 hasConceptScore W4367174013C28328180 @default.
• W4367174013 hasConceptScore W4367174013C3008058167 @default.
• W4367174013 hasConceptScore W4367174013C524204448 @default.
• W4367174013 hasConceptScore W4367174013C54355233 @default.
• W4367174013 hasConceptScore W4367174013C553184892 @default.
• W4367174013 hasConceptScore W4367174013C55493867 @default.
• W4367174013 hasConceptScore W4367174013C71924100 @default.
• W4367174013 hasConceptScore W4367174013C72563966 @default.
• W4367174013 hasConceptScore W4367174013C86803240 @default.
• W4367174013 hasConceptScore W4367174013C8891405 @default.
• W4367174013 hasFunder F4320324962 @default.
• W4367174013 hasIssue "1" @default.
• W4367174013 hasLocation W43671740131 @default.
• W4367174013 hasLocation W43671740132 @default.

• next